Initiation of fracture repair by bone morphogenetic proteins

Clinical Orthopaedics and Related Research

Volumn 355, Issue SUPPL., 1998, Pages

  Reddi, A H ^a,b  

^a University of Illinois School of Medicine   (United States)

^b Research Building I   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN; CYTOPLASM PROTEIN; DNA; OSTEOGENIC PROTEIN 1; OSTEOGENIN; PROTEIN KINASE;

BONE MATRIX; BONE REGENERATION; BONE REMODELING; CONFERENCE PAPER; FRACTURE HEALING; OSSIFICATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FAMILY; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

EID: 0031733405     PISSN: 0009921X     EISSN: 15281132     Source Type: Journal    
DOI: 10.1097/00003086-199810001-00008     Document Type: Conference Paper

References (61)

1. Axhausen G: Die Histologischen und Klinischen Gesetze der Freien Osteoplastik auf grund von Thierversuchen. Arch Klin Chir 88:23-78, 1908.
2. Bank A: Human somatic cell gene therapy. Bioessays 18:999-1007, 1996.
3. Barth A: Uber Osteoplastik. Arch Klin Chir 86:859-897, 1908.
4. Bostrom M, Lane JM, Tomin E, et al: Use of bone morphogenetic protein-2 in the rabbit ulnar nonunion model. Clin Orthop 327:272-282, 1996.
5. Chang SC, Hoang B, Thomas JT, et al: Cartilage-derived morphogenetic proteins. J Biol Chem 269: 28227-28234, 1994.
6. Chen P, Carrington JL, Hammonds RG, Reddi AH: Stimulation of chondrogenesis in limb bud mesodermal cells by recombinant human BMP-2B and modulation by TGF-β1 and TGF-β2. Exp Cell Res 195:509-515, 1991.
7. Chen S, Rubbock MJ, Whitman M: A transcriptional partner for Mad proteins in TGF-β signalling. Nature 383:691-696, 1996.
8. Cunningham NS, Paralkar V, Reddi AH: Osteogenin and recombinant bone morphogenetic protein-2B are chemotactic for human monocytes and stimulate transforming growth factor-β1 mRNA expression. Proc Natl Acad Sci USA 89:11740-11744, 1992.
9. Damien CJ, Parson JR: Bone graft and bone graft substitutes: A review of current technology and applications. J Appl Biomater 2:187-208, 1991.
10. Duboule D: How to make a limb? Science 266: 575-576, 1994.
11. Dudley AT, Lyons KM, Robertson EJ: A requirement for bone morphogenetic protein-7 during development of the mammalian kidney and eye. Genes Dev 9:2795-2807, 1995.
12. Duhamel HL: Sur une racine qui a la Faculte' de Tiendre en Rouge les os des Animaux Vivants. Mem Acad R Sci Paris 52:1-110, 1739.
13. Gegenbaur C: Uber die Bildung des Knochengewebes. Jena Zeitschrift Naturwissenshaften 1: 343-360, 1864.
14. Graff JM, Bansal A, Melton DA: Xenopus Mad proteins transduce distinct subset of signals for the TGF-β superfamily. Cell 85:479-487, 1996.
15. Goodsir J: Anatomical memoirs of John Goodsir. Black, Edinburgh 1868.
16. Griffith DL, Keck PC, Sampath TK, et al: Three-dimensional structure of recombinant human osteogenic protein-1: Structural paradigm for the transforming growth factor-β superfamily. Proc Natl Acad Sci USA 93:878-883, 1996.
17. Hayashi H, Abdollah S, Qiu Y, et al: The MAD-related protein Smad 7 associates with the TGFβ receptor and functions as an antagonist of TGFβ signaling. Cell 89:1165-1173, 1997.
18. Heine B: Versuche uber Knochenregeneration. Springer, Berlin 1836.
19. Heldin CH, Miyazono K, ten Dijke P: TGFβ signaling from cell membrane to nucleus through Smad proteins. Nature 390:465-471, 1997.
20. Hemmati-Brivanlou A, Kelly OG, Melton DA: Follistatin an antagonist of activin is expressed in the Spemann organizer and displays direct neuralizing activity. Cell 77:283-295, 1994.
21. Hollinger J, Mayer M, Buck D, et al: Poly (α-hydroxy acid) carrier for delivering recombinant human bone morphogenetic protein-2 for bone regeneration. J Controlled Release 39:287-304, 1996.
22. Hunter J: The Works of John Hunter. London, Longman 1835.
23. Johnson RL, Tabin CJ: Molecular models for vertebrate limb development. Cell 90:979-990, 1997.
24. Khouri RK, Koudsi B, Reddi AH: Tissue transformation into bone in vivo. JAMA 266:1953-1955, 1991.
25. Lacroix P: Recent investigations on the growth of bone. Nature 156:576-577, 1945.
26. Leriche R, Policard R: The Normal and Pathological Physiology of Bone. London, Kimpton 1927.
27. Levander G: A study of bone regeneration. Surg Gynecol Obstet 67:705-748, 1938.
28. Luo G, Hoffman M, Bronckers ALJ, et al: BMP-7 is an inducer of morphogens and is also required for eye development and skeletal patterning. Genes Dev 9:2808-2820, 1995.
29. Luyten F, Cunningham NS, Ma S, et al: Purification and partial amino acid sequence of osteogenin, a protein initiating bone differentiation. J Biol Chem 265:13377-13380, 1989.
30. Macewen W: The Growth of Bone. Glasgow, Maclehose 1912.
31. Mulligan RC: The basic science of gene therapy. Science 260:926-932, 1993.
32. Ollier L: Traite' Experimental et Clinique de la Regeneration des Os. Masson, Paris 1867.
33. Orell S: Studien uber Knoctenimplantation und knochenneubildung. Acta Chir Scand 74(Suppl): 1-31, 1934.
34. Ozkaynak E, Rueger DC, Drier EA, et al: OP-1 cDNA encodes an osteogenic protein in the TGF-β family. EMBO J 9:2085-2093, 1990.
35. Paralkar VM, Nandedkar AKN, Pointers RH, et al: Interaction of osteogenin, a heparin binding bone morphogenetic protein, with type IV collagen. J Biol Chem 265:17281-17284, 1990.
36. Piccolo S, Sasai Y, Lu B, De Robertis EM: Dorsoventral patterning in Xenopus: Inhibition of ventral signals by direct binding of chordin to BMP-4. Cell 86:589-598, 1996.
37. Reddi AH: Cell biology and biochemistry of endochondral bone development. Collagen Rel Res 1:209-226, 1981.
38. Reddi AH: Extracellular Matrix and Development. In Piez KA, Reddi AH (eds). Extracellular Matrix Biochemistry. New York, Elsevier 247-291, 1984.
39. Reddi AH: Bone and cartilage differentiation. Curr Opinion Gen Dev 4:937-944, 1994.
40. Reddi AH: BMPs: Actions in flesh and bone. Nat Med 3:837-839, 1997.
41. Reddi AH, Anderson WA: Collagenous bone matrix-induced endochondral ossification and hemopoiesis. J Cell Biol 69:557-572, 1976.
42. Reddi AH, Huggins CB: Biochemical sequences in the transformation of normal fibroblasts in adolescent rat. Proc Natl Acad Sci USA 69:1601-1605, 1972.
43. Ripamonti U: Osteoinduction in porous hydroxyapatite implanted in heterotopic sites of different animal models. Biomaterials 17:31-35, 1996.
44. Ripamonti U, Ma S, Reddi AH: The critical role of geometry of porus hydroxyapatite delivery system induction of bone by osteogenin, a bone morphogenetic protein. Matrix 12:202-212, 1992.
45. Ripamonti U, Van den Heever B, Sampath TK, et al: Complete regeneration of bone in the baboon by recombinant human osteogenic protein-1 (hOP-1, bone morphogenetic protein-7). Growth Factors 123:273-289, 1996.
46. Ruoslahti E, Pierschbacher MD: New perspectives in cell adhesion: RGD and integrins. Science 238:491-497, 1987.
47. Sampath TK, Reddi AH: Dissociative extraction and reconstitution of bone matrix components involved in local bone differentiation. Proc Natl Acad Sci USA 78:7599-7603, 1981.
48. Sampath TK, Reddi AH: Homology of bone inductive proteins from human, monkey, bovine, and rat extracellular matrix. Proc Natl Acad Sci USA 80:6591-6595, 1983.
49. Senn N: On the healing of aseptic bone cavities by implantation of antiseptic decalcified bone. Am J Med Sci 98:219-240, 1889.
50. Storm EE, Huynh TV, Copeland NG, et al: Limb alterations in brachypodism mice due to mutations in a new member of TGF-β superfamily. Nature 368:639-642, 1994.
51. ten Dijke P, Yamashita H, Sampath TK, et al: Identification of type I receptors for OP-1 and BMP-4. J Biol Chem 269:16986-16988, 1994.
52. Urist MR: Bone: Formation by autoinduction. Science 150:893-899, 1965.
53. Vukicevic S, Luyten FP, Kleinman HK, Reddi AH: Differentiation of canalicular cell processes in bone cells by basement membrane matrix component: Regulation by discrete domains of laminin. Cell 64:437-445, 1990.
54. Weiss RE, Reddi AH: Synthesis and localization of fibronectin during collagenous matrix mesenchymal cell interaction and differentiation of cartilage and bone in vivo. Proc Natl Acad Sci USA 77:2074-2078, 1980.
55. Wientroub S, Reddi AH: Influence of irradiation on the osteoinductive potential of demineralized bone matrix. Calcif Tissue Int 42:255-260, 1988.
56. Wientroub S, Weiss JF, Catravas GN. Reddi AH: Influence of whole body irradiation and local shielding on matrix-induced endochondral bone differentiation. Calcif Tissue Int 46:38-45, 1990.
57. Winnier G, Blessing M, Labosky PA, Hogan BLM: Bone morphogenetic protein-4 is required for mesoderm formation and patterning in the mouse. Genes Dev 9:2105-2116, 1996.
58. Wozney JM, Rosen V, Celeste AJ, et al: Novel regulators of bone formation: Molecular clones and activities. Science 242:1528-1534, 1988.
59. Yamaguchi K, Shirakabe K, Shibuya H, et al: Identification of a member of the MAPKKK family as a potential mediator of TGF-β signal transduction. Science 270:2008-2011, 1995.
60. Zhang H, Bradley A: Mice deficient of BMP-2 are nonviable and have defects in amnion/chorion and cardiac development. Development 122:2977-2986, 1996.
61. Zimmerman LB, Jesus-Escobar JM, Harland RM: The Spemann organizer signal Noggin binds and inactivates bone morphogenetic protein-4. Cell 86:599-606, 1996.